Scott C. Chappel
28Patents
7h-index
32Co-inventors
69Inventor score
Filing activity: Dec 21, 1987 → Sep 15, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5272071A | Method for the modification of the expression characteristics of an endogenous gene of a given cell line | Chemistry; Metallurgy | 325 | Expired |
| US6096537A | Cells with multiple altered epitopes on a surface antigen for use in transplantation | Chemistry; Metallurgy | 37 | Expired |
| US5679340A | Cells with multiple altered epitopes on a surface antigen for use in transplantation | Chemistry; Metallurgy | 26 | Expired |
| US5260421A | Site-directed mutagenesis modified glycoprotein hormones | Emerging Cross-Sectional Technologies | 21 | Expired |
| US6194177A | DNA encoding a hybrid heterodimeric protein | Chemistry; Metallurgy | 11 | Expired |
| US5240832A | Heteropolymeric protein production methods | Emerging Cross-Sectional Technologies | 9 | Expired |
| US9803016B2 | Anti-CD47 antibodies and methods of use | Chemistry; Metallurgy | 8 | Active |
| US5087615A | Novel method of ovulation induction in humans | Emerging Cross-Sectional Technologies | 7 | Expired |
| US6193972A | Hybrid heterodimeric protein hormone | Chemistry; Metallurgy | 5 | Expired |
| US5352779A | Site-directed mutagenesis modified DNA encoding glycoprotein hormones and methods of use | Emerging Cross-Sectional Technologies | 4 | Expired |
| US10570201B2 | Anti-CD47 antibodies and methods of use | Chemistry; Metallurgy | 3 | Active |
| US10793637B2 | Antibodies that bind CD39 and uses thereof | Physics | 2 | Active |
| US10738128B2 | Antibodies that bind CD39 and uses thereof | Physics | 2 | Active |
| US6348444B1 | Human growth hormone to stimulate hematopoiesis and immune reconstitution after hematopoietic stem cell transplantation in humans | Human Necessities | 1 | Expired |
| US5674711A | Heteropolymeric protein production methods | Emerging Cross-Sectional Technologies | 1 | Expired |
| US5602006A | Heteropolymeric protein production methods | Emerging Cross-Sectional Technologies | 1 | Expired |
| US5986068A | Site-directed mutagenesis modified glycoprotein hormones and methods of use | Emerging Cross-Sectional Technologies | 1 | Expired |
| US5658760A | Heteropolymeric protein production methods | Emerging Cross-Sectional Technologies | 1 | Expired |
| US11332524B2 | Anti-IL-27 antibodies and uses thereof | Physics | 1 | Active |
| US11312783B2 | Antibody molecules to CD73 and uses thereof | Physics | 1 | Active |
| US12358978B2 | Anti-IL-27 antibodies and uses thereof | Physics | 0 | Active |
| US5635475A | Site-directed mutagenesis modified glycoprotein hormones and methods of use | Human Necessities | 0 | Expired |
| US11655303B2 | Anti-CD39 antibody compositions and methods | Chemistry; Metallurgy | 0 | Active |
| US10442858B2 | Anti-CD47 antibodies and methods of use | Chemistry; Metallurgy | 0 | Active |
| US5262518A | Ovulation kit comprising FSH isoforms with varying half-lives | Emerging Cross-Sectional Technologies | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.